Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes.
about
Contribution of bone marrow-derived fibrocytes to liver fibrosisMechanisms of fibrosis: therapeutic translation for fibrotic diseaseFibrocytes and the pathogenesis of diffuse parenchymal lung disease.Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.Following the path of CCL2 from prostaglandins to periostin in lung fibrosisTracking the elusive fibrocyte: identification and characterization of collagen-producing hematopoietic lineage cells during murine wound healing.Pathogenesis of idiopathic pulmonary fibrosisCCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration.Genetic and pharmacological targeting of CSF-1/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression.Amniotic fluid stem cells inhibit the progression of bleomycin-induced pulmonary fibrosis via CCL2 modulation in bronchoalveolar lavageBiphasic presence of fibrocytes in a porcine hypertrophic scar model.Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells.Silica promotes the transdifferentiation of rat circulating fibrocytes in vitroRelationship of clusterin with renal inflammation and fibrosis after the recovery phase of ischemia-reperfusion injuryDiabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis.Vaccinia vaccine-based immunotherapy arrests and reverses established pulmonary fibrosis.Pirfenidone inhibits fibrocyte accumulation in the lungs in bleomycin-induced murine pulmonary fibrosis.Surgical inflammatory stress: the embryo takes hold of the reins again.Function and fate of myofibroblasts after myocardial infarctionThe types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies.Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications.Combinatorial treatment of idiopathic pulmonary fibrosis using nanoparticles with prostaglandin E and siRNA(s).Fibrocytes: emerging effector cells in chronic inflammation.Regulation of IL-17A responses in human airway smooth muscle cells by Oncostatin M.Deletion of c-FLIP from CD11b(hi) Macrophages Prevents Development of Bleomycin-induced Lung Fibrosis.Foxm1 transcription factor is required for lung fibrosis and epithelial-to-mesenchymal transition.Fibrocytes are increased in lung and peripheral blood of patients with idiopathic pulmonary fibrosis.The diversity of myeloid immune cells shaping wound repair and fibrosis in the lung.The wound-healing response and upregulated embryonic mechanisms: brothers-in-arms forever
P2860
Q28083363-F98DE10F-C8E0-4D2E-B066-49DB10EBD48AQ29620307-CEB4CCAE-040E-4C2E-BD82-FC6637352EE8Q30426516-E4D97EEF-B176-4F2E-947A-77142E42E607Q33579016-BA30FD65-A5F8-4929-9628-72213864B8DAQ33799756-160805DF-EE48-4394-B4FF-E13154685519Q33895521-B1574AF5-4E1C-4A47-AFBA-DDA20D6A1FD3Q33976506-6DAADBE2-ABF5-4F9E-B401-A6AE1888CAF4Q34432950-AB629A16-9388-41B0-95EE-6769C9C1FE23Q34571096-69794FE7-6465-4F7C-B224-997739B01E53Q34964361-E449B4B9-57A4-4C9F-AFC6-36E4109BD376Q35395038-E70E993D-2407-4E52-8169-25A7123F3FC6Q35942991-733E0DF6-61AE-43BA-A1C7-37C162A251EEQ36089903-0E85C4F0-F262-4495-9F0B-0DAAB66E5743Q36138680-DB621402-AA0E-48A2-A15E-6772479803E1Q36589609-77BE7EB8-3C80-4464-9AB0-55F7F43B7F38Q36865803-705CF956-BA91-438B-BFE8-DC493D8D7CCAQ37594827-7557609A-B029-43E6-9CEF-FF9E13A7BB14Q38078558-848CD67B-7D37-4997-9CDE-7747F61B5F3DQ38085345-B59DB53C-F5A5-4A46-926F-3956088D6FBFQ38237634-0D5F509C-2BA5-40C0-B813-51234E67B3C7Q38812037-2C94EB38-29A0-4016-910A-5FB380FEA01DQ38824212-D83604B8-1315-44FC-B479-CC52863F0005Q39634075-CDA952CE-2B4C-4088-BF26-ED3237E5A667Q42012743-3B63F005-549D-48C1-8033-A4CCCEE96C24Q42777505-CE898646-39B5-4270-B9C3-683A30999B6CQ42947185-F590845B-56D8-408A-ABF5-8FBBEFBE6575Q54971854-BA07EAE1-4E04-4977-AAE7-0821A1BE32DCQ55046775-6797AC93-37F1-4961-995C-A6F1E3460CBAQ58455103-29C2A7ED-2510-4EBB-A493-C3DE22EFC096
P2860
Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Chemokine (C-C motif) ligand 2 ...... nd murine cultured fibrocytes.
@en
type
label
Chemokine (C-C motif) ligand 2 ...... nd murine cultured fibrocytes.
@en
prefLabel
Chemokine (C-C motif) ligand 2 ...... nd murine cultured fibrocytes.
@en
P2093
P2860
P356
P1476
Chemokine (C-C motif) ligand 2 ...... and murine cultured fibrocytes
@en
P2093
Anuk M Das
Jason E Ekert
Jill Giles-Komar
Michael A Rycyzyn
P2860
P2888
P356
10.1186/1755-1536-4-23
P50
P577
2011-10-19T00:00:00Z
P5875
P6179
1043171791